| Sean Patrick Umstead, PT | |
|
389 Fort Salonga Rd, Northport, NY 11768-3044 | |
| (631) 261-0444 | |
| (631) 261-3112 |
| Full Name | Sean Patrick Umstead |
|---|---|
| Gender | Male |
| Speciality | Physical Therapist |
| Location | 389 Fort Salonga Rd, Northport, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285755686 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 028212 (New York) | Primary |
| Provider Name | New York University |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1285826438 PECOS PAC ID: 1355232422 Enrollment ID: O20081202000185 |
News Archive
Preclinical experiments led by a team of researchers at VCU Massey Cancer Center have shown that blocking the production of a protein known as chromodomain helicase DNA-binding protein 4 (CHD4) may help increase the effectiveness of first-line treatments for acute myeloid leukemia (AML), a particularly lethal blood cancer that is increasing in incidence among older adults.
Dieting could be revolutionized, thanks to the ground-breaking discovery by the University of Warwick of the key brain cells which control our appetite.
Quite simply, in any laparoscopic procedure there are two factors, the surgeon and the patient.
DARA BioSciences, Inc., announced today that SurgiVision, Inc., a privately held company of which DARA owns 1,613,258 shares and warrants to purchase an additional 405,000 shares, has received 510(k) clearance from the Food and Drug Administration (FDA) to market their ClearPoint system in the United States for general neurological interventional procedures.
› Verified 2 days ago
| Provider Name | New York University |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1285826438 PECOS PAC ID: 1355232422 Enrollment ID: O20090822000026 |
News Archive
Preclinical experiments led by a team of researchers at VCU Massey Cancer Center have shown that blocking the production of a protein known as chromodomain helicase DNA-binding protein 4 (CHD4) may help increase the effectiveness of first-line treatments for acute myeloid leukemia (AML), a particularly lethal blood cancer that is increasing in incidence among older adults.
Dieting could be revolutionized, thanks to the ground-breaking discovery by the University of Warwick of the key brain cells which control our appetite.
Quite simply, in any laparoscopic procedure there are two factors, the surgeon and the patient.
DARA BioSciences, Inc., announced today that SurgiVision, Inc., a privately held company of which DARA owns 1,613,258 shares and warrants to purchase an additional 405,000 shares, has received 510(k) clearance from the Food and Drug Administration (FDA) to market their ClearPoint system in the United States for general neurological interventional procedures.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sean Patrick Umstead, PT 389 Fort Salonga Rd, Northport, NY 11768-3044 Ph: (631) 261-0444 | Sean Patrick Umstead, PT 389 Fort Salonga Rd, Northport, NY 11768-3044 Ph: (631) 261-0444 |
News Archive
Preclinical experiments led by a team of researchers at VCU Massey Cancer Center have shown that blocking the production of a protein known as chromodomain helicase DNA-binding protein 4 (CHD4) may help increase the effectiveness of first-line treatments for acute myeloid leukemia (AML), a particularly lethal blood cancer that is increasing in incidence among older adults.
Dieting could be revolutionized, thanks to the ground-breaking discovery by the University of Warwick of the key brain cells which control our appetite.
Quite simply, in any laparoscopic procedure there are two factors, the surgeon and the patient.
DARA BioSciences, Inc., announced today that SurgiVision, Inc., a privately held company of which DARA owns 1,613,258 shares and warrants to purchase an additional 405,000 shares, has received 510(k) clearance from the Food and Drug Administration (FDA) to market their ClearPoint system in the United States for general neurological interventional procedures.
› Verified 2 days ago
Christine Foster, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 20 Woodhull Pl, Northport, NY 11768 Phone: 631-261-8606 | |
Erin Mary Imbasciani, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 40 Main St, Northport, NY 11768 Phone: 631-651-9623 Fax: 631-651-9421 | |
Melissa Cuda, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3 Middleville Rd, Northport, NY 11768 Phone: 631-235-5347 | |
Ejm Prestige Enterprise, Llc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 68 Eatons Neck Rd, Northport, NY 11768 Phone: 516-242-5799 | |
Mr. Robert Joseph Znaniecki I, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 79 Middleville Rd, Northport, NY 11768 Phone: 631-261-4400 | |
Format Pt Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 16 Pocket Ct, Northport, NY 11768 Phone: 917-272-6375 | |
Carlos Alberto Montero, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 79 Middleville Rd, Northport, NY 11768 Phone: 631-261-4400 |